Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Johns Hopkins Researchers Develop Human Stem Cell Line Containing Sickle Cell Anemia Mutation

Published: Tuesday, June 03, 2008
Last Updated: Tuesday, June 03, 2008
Bookmark and Share
Researchers establish a human cell-based system for studying the disease by reprogramming somatic cells to an embryonic stem cell like state.

Researchers at Johns Hopkins have established a human cell-based system for studying sickle cell anemia by reprogramming somatic cells to an embryonic stem cell like state.

Publishing online in Stem Cells on May 29, the team describes an efficient method of reprogramming cells that might speed the development of stem cell therapies.

“We hope our new cell lines can open the doors for researchers who study diseases like sickle cell anemia that are limited by the lack of good experimental models,” says Linzhao Cheng, Ph.D., an associate professor of gynecology and obstetrics, medicine and oncology and a member of the Johns Hopkins Institute for Cell Engineering.

The research team first sought to improve previously established methods for reprogramming of adult cells into so-called induced pluripotent stem (iPS) cells, which look and behave similarly to embryonic stem cells and can differentiate into many different cell types.

After testing several different genes, they were able to improve reprogramming efficiency by adding a viral protein known as SV40 large T antigen.

Using both fetal and adult human skin cells, the researchers introduced the four genes previously reported sufficient for cell reprogramming and compared the efficiency of reprogramming in the presence or absence of large T antigen.

Without large T, cells form embryonic stem cell-like clusters in three to four weeks. With large T, the cells started looking like embryonic stem cells in just 12 to 14 days.

“Not only did T speed up reprogramming, we also found that it increases the total number of reprogrammed cells, which is great because often in reprogramming, not all cells go all the way,” says Cheng, who explains that rigorous follow-up tests are required to determine if the reprogrammed cells really behave like pluripotent embryonic stem cells.

“Many of them look right but they’re probably just half cooked-like a boiled egg, you just can’t tell the difference by looking at the outside,” he says.

Having established a faster, more efficient method, the team then reprogrammed human cells that contain the mutation associated with sickle cell anemia. Embryonic stem cell-like clusters were visible 14 days after they initiated reprogramming and from these clusters the researchers established three different cell lines that both look and behave like human embryonic stem cells.

“One challenge to studying blood diseases like sickle cell anemia is that blood stem cells can’t be kept alive for very long in the lab, so researchers need to keep returning to patients for more cells to study,” says Cheng. “Having these new cell lines available might enable some bigger projects, like screening for potential drugs.”

The research was funded by the National Institutes of Health and the Johns Hopkins Institute for Cell Engineering.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Tumor-Only Genetic Sequencing May Misguide Cancer Treatment in Nearly Half of All Patients
Johns Hopkins scientists say the genetic code of tumors must be compared to patients’ noncancer genome to get a true picture.
Thursday, April 16, 2015
New Genetic and Epigenetic Contributors to Diabetes Identified
Comparison of fat cells in mice and men hints at how genes and environment conspire to produce disease.
Wednesday, January 07, 2015
When DNA Gets Sent to Time-Out
New details revealed in the coordinated regulation of large stretches of DNA.
Tuesday, January 06, 2015
CRISPR Shows Promise in Engineering Human Stem Cells
Johns Hopkins study could advance use of stem cells for treatment and disease research.
Monday, January 05, 2015
Up-close Look at Cancer on the Move
Microscopic view of metastasis could give insight about how to keep cancer in check.
Friday, November 07, 2014
Potential New 'Twist' in Breast Cancer Detection
Mouse studies reveal new and better picture of stem cells that may fuel some breast cancers.
Monday, December 07, 2009
Johns Hopkins Researcher Leads International Effort to Create “Proteinpedia”
A Johns Hopkins researcher has led the effort to compile to date the largest free resource of experimental information about human proteins.
Thursday, February 07, 2008
RNA Shown to Silence Cancer Suppressor Gene
Discovery sheds light on epigenetic mechanisms in tumor development in plants and animals.
Tuesday, January 15, 2008
Cellular Pump Sabotages Cancer Drug Studies that use Glow Chemical
Scientists discover that a widely used means of illuminating cancer cells could undermine studies of the potential value of experimental anti-cancer drugs.
Thursday, January 03, 2008
More Functional DNA in Genome than Previously Thought
Hopkins researchers report that non-coding DNA, that contributes to inherited diseases like Parkinson’s or mental disorders, may be more abundant than we realize.
Thursday, December 20, 2007
Omicia and Johns Hopkins Receive Small Business Technology Transfer Grant from NIH
Omicia recieves a $187,700 grant from NIH to support a collaboration with Johns Hopkins University to identify genetic causes of cardiovascular disease.
Friday, August 17, 2007
Key to Lung Cancer Chemo Resistance Revealed
Products made by a gene called NRF2 normally protect cells from environmental pollutants.
Tuesday, October 17, 2006
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Senor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Understanding Treatment Resistant Melanoma
Researchers have determined how advanced melanoma becomes resistant; a development toward developing treatments.
Investigating ‘Black Box’ of Human Genetics
Investigations into inactive X chromosomes have shown unusual DNA repeat elements are essential for maintaining 3D structure.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!